Tilray Brands, Inc. Long-term Debt, Percentage Bearing Fixed Interest, Amount
Tilray Brands, Inc. (TLRY) had Long-term Debt, Percentage Bearing Fixed Interest, Amount of $0 as of 2023-02-28, per its 10-Q filed 2023-04-10.
Discontinued › Notes › Debt › Long-Term Debt, Other Disclosure
us-gaap:LongtermDebtPercentageBearingFixedInterestAmount · last filed 2023-04-10
- 2023-02-28: Long-term Debt, Percentage Bearing Fixed Interest, Amount $0.00.
- 2022-11-30: Long-term Debt, Percentage Bearing Fixed Interest, Amount $0.00.
- 2022-08-31: Long-term Debt, Percentage Bearing Fixed Interest, Amount $26.27M.
- 2022-05-31: Long-term Debt, Percentage Bearing Fixed Interest, Amount $20.36M; Long-term Debt, Percentage Bearing Fixed Interest, Amount as first filed $17.84M.
| Period end | Long-term Debt, Percentage Bearing Fixed Interest, Amount | Long-term Debt, Percentage Bearing Fixed Interest, Amount as first filed |
|---|---|---|
| 2023-02-28 | $0.00 10-Q · filed 2023-04-10 | |
| 2022-11-30 | $0.00 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $26.27M 10-Q · filed 2022-10-07 | |
| 2022-05-31 | $20.36M 10-Q · filed 2023-04-10 | $17.84M 10-K · filed 2022-07-28 |
| 2022-02-28 | $18.19M 10-Q · filed 2022-04-06 | |
| 2021-11-30 | $18.30M 10-Q · filed 2022-01-10 | |
| 2021-08-31 | $18.97M 10-Q · filed 2021-10-07 | |
| 2021-05-31 | $20.36M 10-K · filed 2022-07-28 | |
| 2020-05-31 | $19.40M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |